Terazosin as First Line Preoperative Blockade in Filipino Patients Diagnosed with Pheochromocytoma

Authors

  • Joseph Bongon Section of Endocrinology and Metabolism Department of Medicine Philippine General Hospital
  • Raymond Oliva Section of Hypertension, Department of Medicine, Philippine General Hospital
  • Lorraine Almelor Section of Hypertension, Department of Medicine, Philippine General Hospital
  • Frances Lina Lantion-Ang Section of Endocrinology and Metabolism, Department of Medicine, Philippine General Hospital

Abstract

Pheochromocytoma, a rare cause of hypertension, is potentially fatal if left untreated. Definitive treatment is resection of the mass. Preoperative blockade is important to improve intraoperative hemodynamic stability and reduce morbidity during resection. Phenoxybenzamine, a non-selective alpha adrenergic blocker, has been widely used as preoperative blockade, but is unavailable in the Philippines. Terazosin, a selective alpha 1 antagonist and is widely available as treatment for benign prostatic hypertrophy, has been documented in reports as a suitable preoperative drug in reducing blood pressure in pheochromocytoma patients. The objective is to present four cases of Filipino pheochromocytoma patients who were treated with terazosin as first line preoperative blockade. Four Filipino patients from the Philippine General Hospital were diagnosed with pheochromocytoma based on biochemical and imaging studies. They were started on different doses of terazosin, the maximum dose as high as 4 mg per day. One patient experienced orthostatic hypotension at this dose, but was resolved after reducing the dose to 3 mg per day. A beta blocker (metoprolol on 3 cases, carvedilol) was added for reduction of the symptoms. One patient was also diagnosed with diabetic ketoacidosis, and was treated as such. Two patients experienced labile changes with blood pressure during resection but were resolved with the use of intravenous nicardipine for elevated blood pressure, and crystalloids during bouts of hypotension. All of the patients' blood pressure returned to normal after resection of the mass.
Terazosin, a selective alpha 1 antagonist, at a maximum dose of 4 mg per day, may be safely given to Filipino patients diagnosed with pheochromocytoma as first line preoperative blockade.

Downloads

Download data is not yet available.

References

Walther MM, Keiser HR, Linehan WM. Pheochromocytoma: evaluation, diagnosis, and treatment. World J Urol. 1999;17:35-39.

Eisenhofer G, Goldstein DS, Walther MM et al. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J Clin Endocrinol Metab. 2003;88:2656-2666.

Zelinka T, Strauch B, Petrak O et al. Increased blood pressure variability in pheochromocytoma compared to essential hypertension patients. J Hypertens. 2005;23:2033-2039.

Zapanti E, Ilias I. Pheochromocytoma: physiopathologic implications and diagnostic evaluation. Ann N Y Acad Sci. 2006;1088:346-360.

Weingarten TN, Cata JP, O'Hara JF et al. Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma. Urology. 2010;76:508-511.

Tauzin-Fin P, Sesay M, Gosse P, Ballanger P. Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma. Br J Anaesth. 2004;92:512-517.

Douma S, Petidis K, Kartali N, Mahera K, Sabanis C, Zamboulis C. Pheochromocytoma presenting as diabetic ketoacidosis. J Diabetes Complications. 2008;22:295-296.

Published

2015-07-31

How to Cite

Bongon, J., Oliva, R., Almelor, L., & Lantion-Ang, F. L. (2015). Terazosin as First Line Preoperative Blockade in Filipino Patients Diagnosed with Pheochromocytoma. Journal of the ASEAN Federation of Endocrine Societies, 30(1), 35. Retrieved from https://asean-endocrinejournal.org/index.php/JAFES/article/view/171

Issue

Section

Case Reports

Most read articles by the same author(s)